Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

STOCKHOLM, April 5, 2018 /PRNewswire/ --

Data describing and explaining Radspherin^® 's mechanism of action has been published in the Journal of Labelled Compounds and Radiopharmaceuticals. The data further supports and supplements proof-of-principle preclinical data that the company has previously published.

An open access copy of the article can be downloaded from the Oncoinvent Publications webpage.

For further information, please contact::
Jan A. Alfheim,
Chief Executive Officer 
Cell: +47-46-44-00-45                                                                                                 
Email: alfheim@oncoinvent.com

IR enquiries:
Ole Peter Nordby,
Chief Financial Officer 
Cell: +47-41-28-71-79 
Email: nordby@oncoinvent.com

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/oncoinvent-as/r/oncoinvent-publishes-data-explaining-radspherin----s-mechanism-of-action,c2488319